Balkrishna Industries Limited has informed the Exchange about Transcript
BALKRISIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balkrishna Industries reported Q1 FY26 standalone revenue of ₹2,759 crores with EBITDA of ₹655 crores (23.8% margin) and PAT of ₹287 crores, down ~40% YoY, hit by a ₹154 crore M2M forex loss. Sales volume stood at 80,664 metric tons, marginally lower YoY, with India contributing ~35% of volumes and growing 14.4% YoY. US tariffs at 10% were shared 40% by the company and 60% by customers, which pressured margins alongside higher India mix. Europe saw a 20% YoY decline due to weak farmer sentiment. Management reiterated FY26 EBITDA margin guidance of 24–25% and blended post-commercialization margins of 23–25%, with TBR/PCR production slated for June–July 2026 and ~₹3,500 crore capex over 3 years. A first interim dividend of ₹4 per share was declared.
Q1 results were weak on the bottom line due to forex losses, tariff impact, and unfavorable product mix, though the company maintained its full-year margin guidance, which is a modest positive signal. Shareholders received an interim dividend of ₹4/share, but near-term stock sentiment may stay cautious until tariff clarity and Europe demand recovery materialize.